Uncomplicated Urinary Tract Infection Market Size
Market Size in USD Bn
CAGR10.4%
| Study Period | 2025-2032 |
| Base Year of Estimation | 2024 |
| CAGR | 10.4% |
| Market Concentration | High |
| Major Players | GlaxoSmithKline, Iterum Therapeutics, Fimbrion Therapeutics, Janssen Pharmaceuticals, Inmunotek and Among Others |
*Disclaimer: Major players are listed in no particular order.
*Source: Coherent Market Insights
Want to purchase customized report?
please let us know !
please let us know !
Uncomplicated Urinary Tract Infection Market Analysis
The uncomplicated urinary tract infection market is estimated to be valued at USD 7.95 Bn in 2025 and is expected to reach USD 15.89 Bn by 2032, growing at a compound annual growth rate (CAGR) of 10.4% from 2025 to 2032. Key factors such as the high and growing geriatric population globally who are prone to urinary tract infections, increasing awareness regarding treatments for urinary tract infections, and the ongoing development of novel drugs are expected to drive the growth of the uncomplicated urinary tract infection market.